Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
University of Nebraska
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
University of Louisville
Fuda Cancer Hospital, Guangzhou
Fuda Cancer Hospital, Guangzhou
SWOG Cancer Research Network
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center